[Pyruvate oxidation and S35-lipoic acid fixation by breast tumor homogenates].
The rate of pyruvic acid oxidation by human mammary gland tumor homogenates is several times lower compared with that by homogenates of the adjacent non-involved tissues. This dependence is especially manifest with malignant tumors, although in this case both in the involved and non-involved tissues the pyruvate oxidation is slower than in benign tumors. In the in vitro experiments the rate of S35 lipoic acid binding by the precipitated in 10000 g fractions of the homogenates in question was the highest for malignant tumors and 3.36 times lower for the adjacent tissues. In benign tumors these values and their correlation were much more lower.
D002293:Adenocarcinoma, Scirrhous / Q000378:metabolism*; D000232:Adenofibroma / Q000378:metabolism*; D001943:Breast Neoplasms / Q000378:metabolism*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D010084:Oxidation-Reduction; D011773:Pyruvates / Q000378:metabolism*; D008063:Thioctic Acid / Q000378:metabolism*
D011773:Pyruvates; D008063:Thioctic Acid
Okislenie piruvata i fiksatsiia S35 lipoevoĭ kisloty gomogenatami opukholi molochnoĭ zhelezy.